| Literature DB >> 35244808 |
Kartik Tiwari1, Sankha Bhattacharya2.
Abstract
Nanosponges are nanosized drug carriers with a three-dimensional structure created by crosslinking polymers. They have the advantage of being able to hold a wide range of drugs of various sizes. Nanosponges come in a variety of shapes and sizes. They are distinguished by the research method used, the type of polymer used, and the type of drug they may contain. Nanosponges are superior to other delivery systems because they can provide a controlled drug release pattern with targeted drug delivery. The period of action, as well as the drug's residence time, may be regulated. Since it is made of biodegradable materials, it has a low toxicity and is safe to use. The efficiency of drug encapsulation is determined by the size of the drug molecule and the amount of void space available. Cancer, enzyme and biocatalyst carrier, oxygen delivery, solubility enhancement, enzyme immobilization, and poison absorbent are some of the applications for nanosponges. The method of preparation, characterization, factors affecting nanosponge development, drug loading and release mechanism, recent developments in this area, and patents filed in the area of nanosponges are all highlighted in this study. Graphical abstract.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35244808 PMCID: PMC8897344 DOI: 10.1007/s10856-022-06652-9
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
Fig. 1Types of nanosponges
Components used in preparation of nanosponges
| Polymer | Copolymer | Crosslinker | Polar solvents |
|---|---|---|---|
| • HyperCrosslinked PolystyreneCyclodextrin (alkoxy carbonyl cyclodextrins) | • Poly(Valerolactone allyl Valerolactone) | • Carbonyl diimidazole | • Ethanol |
| • Poly(Valerolactone allyl Valerolactone oxypanedione) | • Carboxylic acid dianhydrides | • Dimethylacetamide | |
| • Methylβ-Cyclodextrin | • Ethyl cellulose | • Diarylcarbonates | • Dimethylformamide |
| • Hydroxy propyl β- cyclodextrin | • Polyvinyl alcohol | • Dichloromethane | |
| • Poly-Valerolactone | • Diisocyanates | ||
| • Eudragit RS100 | • Glutaraldehyde | ||
| • Acrylic Polymer | • Pyromellitic anhydride | ||
| • 2,2bis(acrylamide)Acetic Acid |
Fig. 2Solvent method
Fig. 3Ultrasound-assisted method
Fig. 4Melt method
Fig. 5Bubble electrospinning
Fig. 6Emulsion solvent diffusion method
Fig. 7Quasi emulsion solvent method
Drugs loaded in nanosponges
| Class of drug | Drug |
|---|---|
| Antianxiety drugs | Lorazepam |
| Antiarrhythmic agents | Amiodarone hydrochloride |
| Antibiotics | Azithromycin, ciprofloxacin, erythromycin, ofloxacin, sulfamethoxazole, trimethoprim, Cephalexin |
| Anticoagulants | Warfarin |
| Anticonvulsants | Carbamezapine, clonazepam, felbamate, primidone |
| Antidiabetic and antihyperlipidemic drugs | Atorvastatin, fenofibrate, glibenclamide, Glipizide, nateglinide |
| Antiepileptic | Phenytoin |
| Antifungal | Econazole nitrate, Griseofulvin, Itraconazole, Ketoconazole, Lansoprazole, Voriconazole |
| Antihistamines | Terfenadine |
| Antihypertensives | Felodipine, nicardipine, nifedipine, telmisartan |
| Antineoplastic agents | Camptothecin, Docetaxel, Etoposide, Exemestane, Flutamide, Paclitaxel, Raloxifene, Tamoxifen |
| Antiretrovirals | Indinavir, Nelfinavir, Ritonavir, Saquinavir |
| Anthelmintics | Albendazole, Mebendazole, Praziquantel |
| Cardiac drugs | Carvedilol, Digoxin, Talinolol |
| Immunosuppressants | Cyclosporine, Sirolimus, Tacrolimus |
Recent advancements in nanosponges
| Name of researcher | Year of research | Title of project | Major finding | Conclusions |
|---|---|---|---|---|
| Monica R.P Rao, Rohini C. Bhingole | 2015 | Nanosponge-based pediatric-controlled release dry suspension of gabapentin for reconstitution | Important decrease in solubility; displayed the desired regulated profile at 12h; improved taste masking | Invivo tests show an improvement in bioavailability by 24.09% relative to pure drugs. |
| Trotta F, et al. | 2016 | Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease | MIP-NSs show a slower, longer release profile; no degradation due to L-DOPA was observed for long-term storage at room temperature when integrated in MIP-NSs. | MIP-NSs are a promising option for L-DOPA storage and managed distribution. |
| Zainuddin R et al. | 2017 | Enhancement of oral bioavailability of Anti-HIV drug rilpivirine HCl through nanosponge formulation | Drug entrapment leads to improved solubility and twofold rise in drug breakdown following the Higuchi release model; enhanced oral bioavailability. | The strategy provides a convenient dosage range for patients with AIDs, minimizing the need for the consumption of medications only in a fed state. |
| Arvapally et al. | 2017 | Formulation and in vitro evaluation Of Glipizide nanosponges | The regression line from the Higuchi plot shows the drug release rate through the diffusion mode and further confirms the diffusion process. | The release kinetics of the optimized formulation was better suited to the Higuchi model and showed a zero-order drug release with the Fickian diffusion mechanism. |
| Momin M et al. | 2018 | Extended-release delivery of Erlotinib glutathione nanosponge for targeting lung cancer | Tumor volume decreased significantly; low doses of drugs are more effective over longer periods of time and are more specific to the target and thus minimize side effects. | Nanosponge can encapsulate high-efficiency anticancer drugs and exhibit extended release, have a higher antiproliferative effect than free drugs and thus display site-specific drug delivery and excellent cellular drug uptake. |
| Jin et al. | 2018 | Deoxyribozyme-nanosponges for improved photothermal therapy by overcoming thermoresistance | In vitro studies have shown that this nanosponge-ICG therapeutic platform can reduce the expression of HSP70 genes or proteins to normal levels during photothermal treatment and thus increase therapeutic efficacy. | Multivalent DNAzyme will effectively silence the HSP70 gene to heat MCF-7 cells, suppressing the heat shock response of cancer cells. |
| Wang et al. | 2019 | Nonviolent Self -Catabolic DNAzyme Nanosponges for Smart Anticancer Drug Delivery | DNAzyme nanosponges have been encoded with multivalent tandem aptamer that helps to deliver cancer cells efficiently; effective and accurate drug administration with synergistically enhanced therapeutic efficiency. | The present DNAzyme NS framework could be built to demonstrate outstanding applications in biomedicine and bioengineering. |
Recent patents
| Sr. no. | Patent/App. No. | Applicant | Title |
|---|---|---|---|
| 1 | W02006002814A1 | Francesco Trotta, Wander Tumiatti, Orfeo Zerbinati, Carlo Roggero, Roberto Vallero | Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 2. | W02009149883A1 | Gianfranco Gilardi, Francesco Trotta, Roberto Cavalli, Paolo Ferruti, Elisabetta Ranucci, Giovanna Di Nardo, Carlo Mario Roggero, Vander Tumiatti | Cyclodextrin nanosponges as a carrier for biocatalysts, and in the delivery and release of enzymes, proteins, vaccines and antibodies. |
| 3. | ITMI20071321A1 | Giovanni Nicolao Berta, Roberta Cavalli, Barbara Mognetti, Carlo Maria Roggero, Francesco Trotta, Vander Tumiatti | Nanosponges based on cyclodextrins as a vehicle for anticancer drugs |
| 4. | W02012147069A1 | Universita DegliStudi Di Torino, Sea Marconi, Technologies Di | Method of preparing dextrin nanosponges |
| 5. | CA2692493A1 | Sea Marconi, Technologies Di Vander Tumiatti, S.A.S, Francessco Trotta, Vander Tumiatti, Roberta Cavalli, Carlo Mario Roggero, Barbar Mognetti, Giovanni, Nicolao Berta | Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs |
| 6. | ITTO20110873A1 | Vecchi Marco DeCarlo Stefano DiShubhen KapilaCarlo Maria RoggeroValentina ScariotMichela Tumiatti | Use of nanosponge functionalized for growth, preservation, protection and disinfection of plant organisms |
| 7. | US9574136B2 | Kun Lian | Nanoparticles, nanosponges, methods of synthesis, and methods of use |
| 8. | US20170152439A1 | Kun Lian | Nanoparticles, nanosponges, methods of synthesis, and methods of use |
| 9. | US8828485B2 | Kun Lian, Qinglin Wu | Carbon-encased metal nanoparticles and sponges as wood/plant preservatives or strengthening fillers |
| 10. | WO2007095454A2 | Kun Lian, Qinglin Wu | Carbon-encased metal nanoparticles and sponges, methods of synthesis, and methods of use |
| 11. | WO2009138998A3 | Eswaramoorthy Muthusamy, Saikrishana Katla | A template free and polymer free metal nanosponge and a process thereof |
| 12. | WO2012147069A1 | Francesco Trotta, Pravin SHENDE, Miriam BIASIZZO | Method for preparing dextrin nanosponges |